Microfluidic Fabrication and Characterization of Sorafenib-loaded Lipid-Polymer Hybrid Nanoparticles for Controlled Drug Delivery

Nayab Tahir, Asadullah Madni, Wei Li, Alexandra Correia, Muhammad Muzamil Khan, Muhammad Abdul Rahim, Hélder A. Santos

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Sammanfattning

Lipid polymer hybrid nanoparticles (LPHNPs) have been merged as potential nanocarriers for treatment of cancer. In the present study, LPHNPs loaded with Sorafenib (SFN) were prepared with PLGA, Lecithin and DSPE-PEG 2000 by using the bulk nanoprecipitation and microfluidic (MF) co-flow nanoprecipitation techniques. Herein, a glass capillary microfluidic device was primed to optimize the LPHNPs and compared to the bulk nanoprecipitation method. The morphological analysis of prepared LPHNPs revealed the well-defined spherical nano-sized particles in bulk nanoprecipitation method. Whereas, core shell morphology was observed in the MF method. The formulation prepared by the MF method (MF1-MF3) indicated relatively higher % EE (95.0%, 93.8% and 88.7%) and controlled release of the SFN from the particles as compared to the LPHNPs obtained by the bulk nanoprecipitation method. However, the release of SFN from all LPHNP formulation followed Higuchi model (R2 = 0.9901-0.9389) with Fickian diffusion mechanism. Fourier transform infrared spectroscopy (FTIR), Differential scanning calorimetry (DSC) and powder X-rays diffraction (pXRD) studies depicted the compatibility of SFN with all the structural components. In addition, the colloidal stability, in vitro cytotoxicity and cell growth inhibition studies of LPHNPs also demonstrated stability in biological media, biocompatibility and safety with enhanced anti-proliferative effects than the free SFN in breast cancer and prostate cancer cells. In conclusion, LPHNPs provided a prospective platform for the cancer chemotherapy and substantially improved the knowledge of fabrication and optimization of the hybrid nanoparticles.
Originalspråkengelska
Artikelnummer119275
TidskriftInternational Journal of Pharmaceutics
Volym581
Antal sidor11
ISSN0378-5173
DOI
StatusPublicerad - 15 maj 2020
MoE-publikationstypA1 Tidskriftsartikel-refererad

Citera det här